| Purpose | Announcement Date | Ex-Date | Record Date | Dividend Amount | Dividend per Share | Remark |
|---|---|---|---|---|---|---|
| Dividend | 28 May 2025 | 19 Sep 2025 | 19 Sep 2025 | 0.1 | 1 | Final |
| Sotac Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 28, 2025, recommended Final Dividend of Rs. 0.10 per equity share. Fixed the Record Date on Friday, September 19, 2025 for the purpose of determining the entitlement of dividend of Rs. 0.10/- per equity share having face value of Rs.10/- per equity share (i.e. 1 % of face value) for the financial year ended March 31, 2025, subject to approval of members at the ensuing 10th Annual General Meeting, will be paid to the eligible members within the stipulated period of 30 days from the date of declaration Recommendation of final dividend of Rs. 0.10/- (Rupees Ten paisa only) per Equity share having face value of Rs.10/- per equity share (i.e. 1.00 % of face value) for the financial year ended on March 31, 2025, subject to the approval of the members at the ensuing Annual General Meeting. | ||||||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.